Research stability of “Uronefron” tablets
DOI:
https://doi.org/10.24959/uekj.17.33Keywords:
“Uronefron” tablets, shelf life, storage conditions, stability, photostabilityAbstract
The study of medicines stability is one of the fundamental issues in quality assurance system. In accordance with developed countries current legislation, the rules of Good Manufacturing Practice, one of the responsibilities of the manufacturer is study of stability, which must be carried out at the stage of active substance and medication development. Aim. To conduct a study of long-term and accelerated stability of tablets “Uronefron”. Results. The article presents the stability study results of “Uronefron” tablets for three experimental batches for 6 months under accelerated tests at the temperature of (40 ± 2) °C and relative humidity of (75 ± 5) % and under conditions of long-term tests at the temperature of (25 ± 2) °C and relative humidity of (60 ± 5) %. A study was conducted to investigate the photostability of the medicine. Conclusions. It is confirmed the compliance of the medicinal drug with the requirements of the specification over time under the influence of temperature, humidity and light.
References
Heorhiievskyi, V. P., Liapunov, M. O., Bezugla, O. P. et al. (2004). Nastanova z yakosti. Likarski zasoby.
Vyprobuvannia stabilnosti. Nastanova 42–3.3.2004. Kyiv: Ministerstvo okhorony zdorovia Ukrainy, 60.
Tykhonov, O. I., Kovalova, O. O. (2012). Akt. pytannia farmats. med. nauky ta praktyky, 3 (10). Zaporizhzhia,
–90.
Derzhavna Farmakopeia Ukrainy, 2 edition. (2015). Kharkiv: Ukrainskyi naukovyi farmakopeinyi tsentr
yakosti likarskykh zasobiv, 1, 1128.
ICH Topic Q1E Evaluation of Stability Data. August 2003 CPMP/ICH/420/02 (2006). EMA, 17.
World Health Organization WHO Technical Report Series (2009). Stability testing of active pharmaceutical
ingredients and finished pharmaceutical products, 953, 130.
Stability Testing of New Drag Substances and Products. ICН Harmonized Tripartite Guideline. (1993).
ICН Expert Working Group. Geneva, 42.
Downloads
Published
Issue
Section
License
Copyright (c) 2017 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
